N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Sacha Bodin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine & Radiopharmacy, CHU de Bordeaux, F-33000 Bordeaux, France. Hauptthemen laut MEDLINE: Neurotensin, Radiopharmaceuticals. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Institut National Du Cancer.
Abstract (Originalsprache)
Peptide-based radiopharmaceuticals targeting neurotensin-receptor-1 (NTS1) are mainly stabilized using chemical modifications at the NT[8-13] sequence, thus increasing the stability and the uptake of the corresponding radionuclide-macrocycle-linker-bioconjugate. We postulate that the introduction of the linker at the N-term part induces additional cleavage sites that can be further stabilized to achieve a prolonged uptake. Double (JMV 7259 and JMV 7222) and triple-stabilized neurotensin analogues (JMV 7258 and JMV 7490) were synthesized, radiolabeled, and evaluated on HT-29 cells (NTS1+). Nanomolar NTS1-affinity and high internalization rates were observed for all of the radiopharmaceuticals. Efflux was lower for radiolabeled JMV 7490. Consequently, [111In]In-JMV 7490 showed uptake of 5.86 ± 0.86 and 3.65 ± 0.29% ID/g of tissue in HT-29 xenografts at 1 and 4 h, respectively. We have successfully shown that high and persistent uptake of NTS1-positive tumor cells is achievable by stabilization of the N-term part. Efflux also appears to be a critical parameter for the successful targeting of NTS1 using radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine & Radiopharmacy, CHU de Bordeaux, F-33000 Bordeaux, France.
- CNRS, EPHE, INCIA, UMR 5287, University of Bordeaux, F-33000 Bordeaux, France.
- Department of Radiology & Nuclear Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
- Institut des Biomolécules Max Mousseron, IBMM, UMR 5247, CNRS, Université de Montpellier, ENSCM, 1919 route de Mende, 34293 Montpellier Cedex 5, France.
- INSERM, Institut National de la Recherche Agronomique, Centre de Recherche en Cardiovasculaire et Nutrition, Aix-Marseille University, 13385 Marseille, France.
- Centre Européen de Recherche en Imagerie Médicale, Aix-Marseille University, 13005 Marseille, France.
ORCID-Profile: Sacha Bodin, Tyrillshall S T Damiana, Emmanuelle Rémond, Florine Cavelier, Clément Morgat
Förderung
- Institut National Du Cancer
Zitieren
APA
Bodin, S., Damiana, T. S. T., Previti, S., Balasse, L., Ali, L., Rémond, E., Nail, V., Lamare, F., Hindié, E., Guillet, B., Vimont, D., Dalm, S. U., Cavelier, F., & Morgat, C. (2025). N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02844
Vancouver
Bodin S, Damiana TST, Previti S, Balasse L, Ali L, Rémond E, et al. N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02844
BibTeX
@article{Bodin2025,
author = {Bodin, Sacha and Damiana, Tyrillshall S T and Previti, Santo and Balasse, Laure and Ali, Lina and Rémond, Emmanuelle and Nail, Vincent and Lamare, Frédéric and Hindié, Elif and Guillet, Benjamin and Vimont, Delphine and Dalm, Simone U and Cavelier, Florine and Morgat, Clément},
title = {N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02844}
}
EUVIMED